Accolade Stock News

Accolade (ACCD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Accolade (ACCD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Accolade went public in July 2020, raising $220 million in a U.S. IPO. The firm provides a healthcare information platform for enterprises and end users.

SEATTLE, Dec. 16, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), the company reinventing healthcare by helping people live their healthiest lives, today announced that it will release fisc

SEATTLE, Dec. 16, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), the company reinventing healthcare by helping people live their healthiest lives, today announced that it will release fiscal third quarter 2022 financial results on Monday, January 10, 2022, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. E.T. on the same day.

Calamos Advisors LLC decreased its position in shares of Accolade, Inc. (NASDAQ:ACCD) by 75.4% during the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 11,658 shares of the companys stock after selling 35,751 shares during the period. Calamos Advisors LLCs holdings in Accolade were []

SEATTLE, Dec. 16, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), the company reinventing healthcare by helping people live their healthiest lives, today announced that it will release fiscal

Accolade brings benefits technology and healthcare navigation together to help every person live their healthiest life Accolade brings benefits technology and healthcare navigation together to help every person live their healthiest life

Accolade Inc. (NASDAQ:ACCD)s traded shares stood at 0.71 million during the last session. At the close of trading, the stocks price was $24.47, to imply a decrease of -1.13% or -$0.28 in intraday trading. The ACCD shares 52-week high remains $65.25, putting it -166.65% down since that peak but still an impressive 3.92% since price Accolade Inc. (NASDAQ: ACCD) Shares Fall :-153.37% From The Trough But Can It Keep Going? Read More »

Accolade, Inc. (NASDAQ:ACCD) has been assigned a consensus recommendation of Buy from the thirteen brokerages that are covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation and twelve have given a buy recommendation to the company. The average 1 year price target among analysts that have [] The post Accolade, Inc. (NASDAQ:ACCD) Given Average Rating of Buy by Brokerages appeared first on ETF Daily News .

Shares of Accolade, Inc. (NASDAQ:ACCD) hit a new 52-week low during trading on Monday . The company traded as low as $25.57 and last traded at $25.91, with a volume of 26423 shares trading hands. The stock had previously closed at $27.13. A number of equities analysts have weighed in on ACCD shares. Credit Suisse []

SEATTLE, Nov. 29, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves over 400 employers and millions of members, will participate in the Piper Sandler 33rd Ann

SEATTLE, Nov. 29, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (NASDAQ: ACCD), a healthcare provider that serves over 400 employers and millions of members, will participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference. A presentation is available for registered attendees via the Piper Sandler conference site until December 2, 2021 or can also be accessed at ir.accolade.com.

Shares of Accolade, Inc. (NASDAQ:ACCD) have been assigned a consensus rating of Buy from the twelve ratings firms that are presently covering the firm, MarketBeat.com reports. One investment analyst has rated the stock with a sell recommendation and eleven have issued a buy recommendation on the company. The average 1 year target price among brokerages []

DALLAS, Nov. 18, 2021 /PRNewswire/ -- Employer Direct Healthcare, a leader in healthcare solutions for self-funded employers, today announced their partnership with Accolade, a healthcare provider serving millions of people and their families. This partnership will advance the shared